Radioembolization With Chemotherapy for Colorectal Liver Metastases: A Randomized, Open-Label, International, Multicenter, Phase III Trial.
Mary F MulcahyArmeen MahvashMarc PrachtAmir H MontazeriSteven BandulaRobert C G MartinKen HerrmannEwan BrownDarryl ZuckermanGregory WilsonTae-You KimAndrew WeaverPaul RossWilliam P HarrisJanet GrahamJamie MillsAlfonso Yubero EstebanMatthew S JohnsonConstantinos T SofocleousSiddharth A PadiaRobert J LewandowskiEtienne GarinPhilip SinclairRiad Salemnull nullPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
The addition of TARE to systemic therapy for second-line CLM led to longer PFS and hPFS. Further subset analyses are needed to better define the ideal patient population that would benefit from TARE.